Halia Therapeuticsto Participate in the 6th Annual Needham Private Biotech & MedTech Company Virtual 1x1 Forum
Lehi
Archived
•
October 7, 2026
•
LEHI, Utah, Oct. 7, 2026 /PRNewswire/ -- Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company developing first-in-class therapies targeting inflammasome-driven disease biology, today announced that the Company plans to participate in the 6th Annual Needham Private Biotech & MedTech Company Virtual…
Source: The Leader (Tremonton) | https://www.tremontonleader.com/search/?f=rss&t=article&l=50&c=news* - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



